ALKEM LABORATORIES LIMITED

Communiqués Alkem Laboratories Limited

Actions

ALKEM

INE540L01014

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:01:32 13/12/2024			Varia. 5j.	Varia. 1 janv.
5 372,55 ^INR	-1,15%		-2,41%	+3,27%

15/11	ALKEM LABORATORIES LIMITED : Nomura conserve son opinion neutre	ZM
15/11	Le bénéfice consolidé d'Alkem Laboratories augmente au cours du deuxième trimestre fiscal	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Biosergen Completes Enrollment of First Cohort in BSG005 Proof-of-Concept Trial	07/10	AQ
Legal Insights On Pharma Trademark Similarity And Confusion	19/09	AQ
Exactech Enters Landmark Agreement with Alkem MedTech Pvt Ltd for Manufacturing and Marketing Knee and Hip Replacement Implants in India	23/08	AQ
Exactech and Alkem MedTech form partnership to begin distribution of knee and hip replacement technology in India	23/08	AQ
First Patient in Biosergen Clinical Trial Treating with BSG005 for Life Threatening Fungal Infection	12/07	AQ
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	12/02	AQ
Research Update Biosergen: Licensing deal with Alkem and CTA submission	16/01	AQ
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy	12/12	AQ
Biosergen and Alkem Laboratories Ltd collaborates to develop anti-infective for severe fungal infections	25/09/23	AQ
Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India	10/03/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !